CAS RN: 955406-45-8
4,5,6,7-TETRAHYDRO-1H-INDAZOL-7-AMINE
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250510
100mg / 250mg
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 955406-45-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
955406-45-8 / 4,5,6,7-tetrahydro-1H-indazol-7-amine
Standard CAS: 955406-45-8
Multi CAS: No
Basic Information
copy
CAS
955406-45-8 copy
Multi CAS
No copy
Molecular Formula
C7H11N3 copy
Molecular Weight
137.180000 copy
Exact Mass
137.095297 copy
InChI
InChI=1S/C7H11N3/c8-6-3-1-2-5-4-9-10-7(5)6/h4,6H,1-3,8H2,(H,9,10) copy
InChIKey
WOALOICTMCSWHN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.57 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
38.45 copy
TPSA
54.7 copy
LogP / Solubility
WLOGP
0.75 copy
MLOGP
0.65 copy
XLogP3
-0.1 copy
Consensus LogP
0.43 copy
Log S (ESOL)
-1.53 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.22 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.17 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.03 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy